Stock CVKD CADRENAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Cadrenal Therapeutics, Inc.

Equities

CVKD

US1276361086

Market Closed - Nasdaq
Other stock markets
 21:30:00 05/06/2024 BST 		5-day change 1st Jan Change
0.5098 USD +6.21% Intraday chart for Cadrenal Therapeutics, Inc. +23.59% -31.10%
05-09 Cadrenal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-09 Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bullish

Bearish

Bearish

Resistance 0.5289 0.8500 0.6924
Spread/Res.-3.61%-40.02%-26.37%
Spread/Supp.+14.98%+30.75%+26.94%
Support 0.4434 0.3899 0.4016

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. CVKD Stock
  4. Charts Cadrenal Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW